Legal & General Group PLC Contrafect Corp Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$3.58 - $4.9 $9,791 - $13,401
-2,735 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$4.46 - $6.68 $566 - $848
-127 Reduced 4.44%
2,735 $13,000
Q3 2020

Nov 13, 2020
BUY
$5.05 - $6.99 $3,277 - $4,536
649 Added 29.33%
2,862 $15,000
Q2 2020

Aug 14, 2020
BUY
$4.69 - $7.81 $10,378 - $17,283
2,213 New
2,213 $14,000

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email